Duchenne Muscular Dystrophy (DMD) Treatment Market Size, Share, Opportunities, And Trends By Tests (Blood Test, Molecular, Genetic Testing, Electromyography, Muscle Biopsy), By Treatment (Physical Therapy, Orthopedic Devices, Steroids, Others), And By Geography - Forecasts From 2025 To 2030

$3,950

Single User License

Access Full Insights

Report Overview Table of Contents Customize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

Duchenne Muscular Dystrophy (DMD) Treatment Market Report

Report IDKSI061612301

PublishedNov 2025

Pages140

FormatPDF, Excel, PPT, Dashboard

⬇️ Download Free Sample

📞 Speak to Analyst

Need Assistance?

Our research team is available to answer your questions.

Frequently Asked Questions

The duchenne muscular dystrophy (DMD) treatment market is expected to reach a total market size of US$10,954.230 million by 2030.

Duchenne Muscular Dystrophy (DMD) Treatment Market is valued at US$5,415.322 million in 2025.

The duchenne muscular dystrophy (DMD) treatment market is expected to grow at a CAGR of 15.13% during the forecast period.

The North American region is anticipated to hold a significant share of the duchenne muscular dystrophy (DMD) treatment market.

Prominent key market players in the duchenne muscular dystrophy (DMD) treatment market include NIPPON SHINYAKU CO., LTD., ITALFARMACO S.p.A., FibroGen, Inc., DAIICHI SANKYO COMPANY, LIMITED., Solid Biosciences Inc., among others.

Need data specifically for your business?Request Custom Research →

Related Reports

Duchenne Muscular Dystrophy (DMD) Pipeline Analysis Market - Strategic Insights and Forecasts (2026-2031)

Healthcare•Mar 2026

Needle-Free Injector Market Size, Share, Opportunities, And Trends By Type (Liquid-based Needle-free Injectors, Projectile-based Needle-free Injectors, Powder-based Needle-free Injectors), By Product (Fillable, Prefilled), By Technology (Jet-based Needle-free Injectors, Spring-based Needle-free Injectors, Microarray Patch Injectors, Others), By Usability (Disposable, Reusable), By Application (Vaccine Delivery, Insulin Delivery, Oncology, Pain Management, Dermatology, Others), By Delivery Site (Subcutaneous, Intramuscular, Intradermal), By End-user (Hospitals, Hospitals & Clinics, Home Care Settings, Research Laboratories, Others), And By Geography - Forecasts From 2024 To 2029

Healthcare•Dec 2025

Corneal Implants Market Size, Share, Opportunities, And Trends By Type of Corneal Implants (Penetrating Keratoplasty (PKP), Deep Anterior Lamellar Keratoplasty (DALK), Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK)), By Source of Corneal Tissue (Allografts, Synthetic Corneal Implants), By Indication (Corneal Scarring, Fuchs’ Endothelial Dystrophy, Bullous Keratopathy, Other Corneal Diseases), By End-User (Hospitals, Eye Banks, Ambulatory Surgery Centers (ASCs)), And By Geography - Forecasts From 2024 To 2029

Healthcare•Feb 2024

Generic Injectables For Infectious Diseases Market Size, Share, Opportunities, And Trends By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Vaccines, Small Molecule Antibiotics, Chemotherapy Agents, Others), By Molecule Type (Small Molecule, Large Molecule), By Route of Administration (Intramuscular, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), And By Geography - Forecasts From 2024 To 2029

Healthcare•Jan 2024

Spinal Muscular Atrophy Treatment Market Size, Share, Opportunities, And Trends By Type (Type 1, Type 2, Type 3, Type 4), By Drug (Spinraza, Zolgensma, Evrysdi, Others), By Route of Administration (Oral, Injection), And By Geography - Forecasts From 2024 To 2029

Healthcare•Jun 2024

View All Reports

Trusted by the world's leading organizations